{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:50:16Z","timestamp":1794624616679,"version":"4.9.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.neurol.2024.07.001","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T21:26:33Z","timestamp":1725312393000},"page":"1071-1077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impulse control disorder: Review on clinical, pharmacologic, and genetic risk factors"],"prefix":"10.1016","volume":"180","author":[{"given":"V.","family":"Leclercq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-C.","family":"Corvol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurol.2024.07.001_bib0310","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/WCO.0000000000000955","article-title":"Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and management","volume":"34","author":"Faouzi","year":"2021","journal-title":"Curr Opin Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2024.07.001_bib0315","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1212\/WNL.0000000000007942","article-title":"Impulse control disorders in Parkinson disease and RBD: a longitudinal study of severity","volume":"93","author":"Baig","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2024.07.001_bib0320","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s42466-019-0013-5","article-title":"Neurobiology and clinical features of impulse control failure in Parkinson's disease","volume":"1","author":"B\u00e9reau","year":"2019","journal-title":"Neurol Res Pract"},{"issue":"2","key":"10.1016\/j.neurol.2024.07.001_bib0325","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.psc.2020.02.001","article-title":"Neuropsychiatric aspects of impulse control disorders","volume":"43","author":"Silva","year":"2020","journal-title":"Psychiatr Clin North Am"},{"issue":"7","key":"10.1016\/j.neurol.2024.07.001_bib0330","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","article-title":"Prevalence of repetitive and reward-seeking behaviors in Parkinson disease","volume":"67","author":"Voon","year":"2006","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurol.2024.07.001_bib0335","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2024.07.001_bib0340","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/jnnp-2015-311827","article-title":"Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease","volume":"87","author":"Smith","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.neurol.2024.07.001_bib0345","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1212\/WNL.0000000000005816","article-title":"Longitudinal analysis of impulse control disorders in Parkinson disease","volume":"91","author":"Corvol","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2024.07.001_bib0350","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/21556660.2019.1675670","article-title":"Risk factors for impulse control disorders and related behaviors in Parkinson's disease: secondary analyses of the ICARUS study","volume":"8","author":"Barone","year":"2019","journal-title":"J Drug Assess"},{"issue":"1","key":"10.1016\/j.neurol.2024.07.001_bib0355","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jocn.2013.02.032","article-title":"Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients","volume":"21","author":"Phu","year":"2014","journal-title":"J Clin Neurosci"},{"issue":"6","key":"10.1016\/j.neurol.2024.07.001_bib0360","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2165\/00002018-200932060-00004","article-title":"Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention","volume":"32","author":"Antonini","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.neurol.2024.07.001_bib0365","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/bs.irn.2017.04.006","article-title":"Impulse control and related disorders in Parkinson's disease","volume":"133","author":"Weintraub","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"5","key":"10.1016\/j.neurol.2024.07.001_bib0370","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1017\/S1041610220000253","article-title":"Excessive charity: a new aspect of impulse control disorders in Parkinson's disease?","volume":"32","author":"El Otmani","year":"2020","journal-title":"Int Psychogeriatr"},{"issue":"8","key":"10.1016\/j.neurol.2024.07.001_bib0375","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.parkreldis.2011.06.001","article-title":"Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist","volume":"17","author":"Auyeung","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"10.1016\/j.neurol.2024.07.001_bib0380","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2024.07.001_bib0385","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fneur.2019.00086","article-title":"Medications, deep brain stimulation, and other factors influencing impulse control disorders in Parkinson's disease","volume":"10","author":"Eisinger","year":"2019","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2024.07.001_bib0390","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.comppsych.2007.03.008","article-title":"Comparison of personality risk factors in bulimia nervosa and pathological gambling","volume":"48","author":"\u00c1lvarez-Moya","year":"2007","journal-title":"Compr Psychiatry"},{"issue":"2","key":"10.1016\/j.neurol.2024.07.001_bib0395","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10072-022-06485-y","article-title":"Screening for impulse control disorders in Parkinson's disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors","volume":"44","author":"Contin","year":"2023","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.neurol.2024.07.001_bib0400","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ana.25581","article-title":"Depression as a risk factor for impulse control disorders in Parkinson disease","volume":"86","author":"Mar\u00edn-Lahoz","year":"2019","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2024.07.001_bib0405","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00415-019-09588-3","article-title":"Association between REM sleep behavior disorder and impulsive\u2013compulsive behaviors in Parkinson's disease: a systematic review and meta-analysis of observational studies","volume":"267","author":"Lu","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2024.07.001_bib0410","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.sleep.2018.02.004","article-title":"Impulse control disorders in Parkinson's disease patients with RLS: a cross sectional-study","volume":"48","author":"Marques","year":"2018","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.neurol.2024.07.001_bib0415","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/aian.aian_940_22","article-title":"Impulse-control disorders and restless leg syndrome in Parkinson's disease: association or coexistence","volume":"26","author":"Paul","year":"2023","journal-title":"Ann Indian Acad Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2024.07.001_bib0420","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/jnnp-2013-305395","article-title":"Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels","volume":"85","author":"Voon","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2024.07.001_bib0425","doi-asserted-by":"crossref","first-page":"1191338","DOI":"10.3389\/fnins.2023.1191338","article-title":"Association between metabolic syndrome components and impulse control disorders in Parkinson's disease","volume":"17","author":"Chen","year":"2023","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1016\/j.neurol.2024.07.001_bib0430","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/WCO.0b013e3283489687","article-title":"Impulse control disorders in Parkinson's disease: recent advances","volume":"24","author":"Voon","year":"2011","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2024.07.001_bib0435","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.22164","article-title":"Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study","volume":"68","author":"Weintraub","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2024.07.001_bib0440","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fneur.2018.00109","article-title":"Dopaminergic and opioid pathways associated with impulse control disorders in Parkinson's disease","volume":"9","author":"Erga","year":"2018","journal-title":"Front Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2024.07.001_bib0445","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","article-title":"Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study","volume":"85","author":"Garcia-Ruiz","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.neurol.2024.07.001_bib0450","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/ene.13034","article-title":"A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists","volume":"23","author":"Rizos","year":"2016","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2024.07.001_bib0455","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/WNF.0000000000000091","article-title":"Infusion therapies and development of impulse control disorders in advanced Parkinson disease: clinical experience after 3 years\u2019 follow-up","volume":"38","author":"Todorova","year":"2015","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"10.1016\/j.neurol.2024.07.001_bib0460","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.26067","article-title":"EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease: apomorphine and levodopa in PD","volume":"30","author":"Martinez-Martin","year":"2015","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.neurol.2024.07.001_bib0465","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41531-021-00194-7","article-title":"Long-term effect of apomorphine infusion in advanced Parkinson's disease: a real-life study","volume":"7","author":"Meira","year":"2021","journal-title":"Npj Park Dis"},{"issue":"12","key":"10.1016\/j.neurol.2024.07.001_bib0470","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","article-title":"Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs","volume":"174","author":"Moore","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.neurol.2024.07.001_bib0475","doi-asserted-by":"crossref","first-page":"e00904","DOI":"10.1002\/brb3.904","article-title":"Impulse control disorders in Parkinson's: sleep disorders and nondopaminergic associations","volume":"8","author":"Carbunaru","year":"2018","journal-title":"Brain Behav"},{"key":"10.1016\/j.neurol.2024.07.001_bib0480","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jns.2016.07.003","article-title":"The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: a cross-sectional multicenter study","volume":"368","author":"Vela","year":"2016","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.neurol.2024.07.001_bib0485","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.22029","article-title":"Pathological gambling in Parkinson disease is reduced by amantadine","volume":"68","author":"Thomas","year":"2010","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2024.07.001_bib0490","doi-asserted-by":"crossref","first-page":"e29768","DOI":"10.1371\/journal.pone.0029768","article-title":"Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome. Oreja-Guevara C, editor","volume":"7","author":"Moum","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2024.07.001_bib0495","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.parkreldis.2017.08.006","article-title":"Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapy","volume":"44","author":"Rossi","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"10.1016\/j.neurol.2024.07.001_bib0500","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/mdc3.13738","article-title":"Course of Impulse control disorder symptoms in Parkinson's disease: deep brain stimulation versus medications","volume":"10","author":"Hernandez-Con","year":"2023","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"10.1016\/j.neurol.2024.07.001_bib0505","first-page":"169","article-title":"Neuropsychiatric effects of bilateral subthalamic nucleus (STN) deep brain stimulation in Parkinson's disease; results at the 12-month follow-up","volume":"60","author":"Erdem","year":"2022","journal-title":"Arch Neuropsychiatry"},{"issue":"2","key":"10.1016\/j.neurol.2024.07.001_bib0510","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mds.29700","article-title":"Management of impulse control and related disorders in Parkinson's disease: an expert consensus","volume":"39","author":"Debove","year":"2024","journal-title":"Mov Disord"},{"issue":"9","key":"10.1016\/j.neurol.2024.07.001_bib0515","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1046\/j.1360-0443.1998.93913758.x","article-title":"Familial influences on gambling behavior: an analysis of 3359 twin pairs","volume":"93","author":"Lin","year":"1998","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.neurol.2024.07.001_bib0520","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/archpsyc.57.7.666","article-title":"Common genetic vulnerability for pathological gambling and alcohol dependence in men","volume":"57","author":"Slutske","year":"2000","journal-title":"Arch Gen Psychiatry"},{"issue":"15","key":"10.1016\/j.neurol.2024.07.001_bib0525","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jpsychires.2010.04.006","article-title":"A family history study of intermittent explosive disorder","volume":"44","author":"Coccaro","year":"2010","journal-title":"J Psychiatr Res"},{"issue":"1","key":"10.1016\/j.neurol.2024.07.001_bib0530","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1021271029163","article-title":"Genetics of pathological gambling","volume":"19","author":"Ibanez","year":"2003","journal-title":"J Gambl Stud"},{"issue":"4","key":"10.1016\/j.neurol.2024.07.001_bib0535","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/adb.12378","article-title":"Pathological gambling: a review of the neurobiological evidence relevant for its classification as an addictive disorder: pathological gambling","volume":"22","author":"Fauth-B\u00fchler","year":"2017","journal-title":"Addict Biol"},{"issue":"8","key":"10.1016\/j.neurol.2024.07.001_bib0540","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/mp.2014.113","article-title":"Addiction-related genes in gambling disorders: new insights from parallel human and pre-clinical models","volume":"20","author":"Lobo","year":"2015","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10.1016\/j.neurol.2024.07.001_bib0545","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s12031-012-9846-x","article-title":"Family-based association analysis of serotonin genes in pathological gambling disorder: evidence of vulnerability risk in the 5HT-2A receptor gene","volume":"49","author":"Wilson","year":"2013","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neurol.2024.07.001_bib0550","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.eurpsy.2016.04.001","article-title":"Genome-wide association study of pathological gambling","volume":"36","author":"Lang","year":"2016","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.neurol.2024.07.001_bib0555","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.parkreldis.2020.03.017","article-title":"Parkinson's disease polygenic risk score is not associated with impulse control disorders: a longitudinal study","volume":"75","author":"Ihle","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2024.07.001_bib0560","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.parkreldis.2021.04.003","article-title":"Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scores","volume":"86","author":"Faouzi","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"issue":"14","key":"10.1016\/j.neurol.2024.07.001_bib0565","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1212\/WNL.0000000000003177","article-title":"Impulsive-compulsive behaviors in parkin-associated Parkinson disease","volume":"87","author":"Morgante","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2024.07.001_bib0570","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.parkreldis.2016.05.017","article-title":"Tryptophan hydroxylase type 2 variants modulate severity and outcome of addictive behaviors in Parkinson's disease","volume":"29","author":"Cilia","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2024.07.001_bib0575","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.parkreldis.2016.06.005","article-title":"Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients","volume":"30","author":"Krishnamoorthy","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10.1016\/j.neurol.2024.07.001_bib0580","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/mds.22678","article-title":"Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease: DRD3 and GRIN2B on ICRB in PD","volume":"24","author":"Lee","year":"2009","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.neurol.2024.07.001_bib0585","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12883-015-0316-2","article-title":"DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson's disease patients","volume":"15","author":"Zainal Abidin","year":"2015","journal-title":"BMC Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2024.07.001_bib0590","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.parkreldis.2011.08.009","article-title":"Genetic variant of HTR2A associates with risk of impulse control and repetitive behaviors in Parkinson's disease","volume":"18","author":"Lee","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10.1016\/j.neurol.2024.07.001_bib0595","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/mds.27519","article-title":"Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease","volume":"33","author":"Cormier-Dequaire","year":"2018","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.neurol.2024.07.001_bib0600","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/jnnp-2019-322453","article-title":"Spectrum of impulse control behaviours in Parkinson's disease: pathophysiology and management","volume":"91","author":"Kelly","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.neurol.2024.07.001_bib0605","first-page":"1","article-title":"Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state","volume":"9","author":"Galvan","year":"2015","journal-title":"Front Neuroanat"},{"issue":"6","key":"10.1016\/j.neurol.2024.07.001_bib0610","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12576-016-0445-4","article-title":"Neuronal circuits and physiological roles of the basal ganglia in terms of transmitters, receptors and related disorders","volume":"66","author":"Yamada","year":"2016","journal-title":"J Physiol Sci"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378724005794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378724005794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T21:18:06Z","timestamp":1732742286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378724005794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0035378724005794"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2024.07.001","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impulse control disorder: Review on clinical, pharmacologic, and genetic risk factors","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2024.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}